🇺🇸 FDA

Intelligence · Clinical Pipeline

R&D Pipeline Programs

ClinicalTrials.gov programs linked to pharma sponsors — phase, modality, and trial IDs for BD and competitive intelligence.

Programs indexed
18,156
Companies
1,062
Drugs tracked
3,385

Quick answer

NovaPharmaNews tracks 18,156 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text — searchable for business development and competitive intelligence.

18 results for “Quantum” Clear

  1. Firibastat

    Quantum Biopharma

    Hypertension

    phase 3 small molecule completed

    1 trial

  2. Firibastat (QGC001) Period 1

    Quantum Biopharma

    Hypertension (HTN)

    phase 3 small molecule terminated

    1 trial

  3. Dendritic Cell Vaccination

    Quantum Biopharma

    Breast Cancer

    phase 2 mab active

    1 trial

  4. FSD201

    Quantum Biopharma

    COVID-19

    phase 2 small molecule terminated

    1 trial

  5. FSD201

    Quantum Biopharma

    Mast Cell Activation Syndrome

    phase 2 small molecule terminated

    1 trial

  6. QGC001

    Quantum Biopharma

    Heart Failure

    phase 2 small molecule terminated

    1 trial

  7. QGC001

    Quantum Biopharma

    Essential Hypertension

    phase 2 small molecule completed

    1 trial

  8. QGC001

    Quantum Biopharma

    Hypertension

    phase 2 small molecule completed

    1 trial

  9. Ramipril

    Quantum Biopharma

    Myocardial Infarction

    phase 2 small molecule completed

    1 trial

  10. Dendritic Cell Vaccination

    Quantum Biopharma

    Metastatic Breast Cancer

    phase 1 mab active

    1 trial

  11. Firibastat

    Quantum Biopharma

    Healthy Males

    phase 1 small molecule completed

    1 trial

  12. Lucid-21-302

    Quantum Biopharma

    Healthy Participants

    phase 1 small molecule completed

    1 trial

  13. Lucid-21-302

    Quantum Biopharma

    Heathy Participants

    phase 1 small molecule completed

    1 trial

  14. QGC001 [(3S,3'S)-4,4'-dithiobis (3-aminobutane-1-sulfonic acid)]

    Quantum Biopharma

    Essential Hypertension

    phase 1 small molecule completed

    2 trials

  15. firibastat

    Quantum Biopharma

    Healthy Volunteers

    phase 1 small molecule completed

    1 trial

  16. FSD-F2R6-A-CP

    Quantum Biopharma

    Acute Alcohol Intoxication

    other completed

    1 trial

  17. New Infant Cereal

    Quantum Biopharma

    Infant Nutrition Sciences

    other completed

    1 trial

  18. Symbiotic Formula with DHA and antioxidants

    Quantum Biopharma

    Cystic Fibrosis

    other completed

    1 trial

Frequently asked questions

What is the NovaPharmaNews pipeline directory?

It is a searchable index of 18,156 clinical development programs grouped by sponsor company, with phase (Phase 1–3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.

Where does pipeline data come from?

Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.

How do I find pipeline programs by company or phase?

Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.

Data attribution and licensing: Data sources